Clinical Trial Update: A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing HRS-7535 with dapagliflozin in adults with Type 2 diabetes inadequately controlled with metformin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• HRS-7535 (HRS-7535)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED